Latest
In awe of molecular tools
The Research Briefing is powered by Blossom, a psychedelic research database. Blossom helps you find scientific insights in this new blossoming era of psychedelic research. Find the latest papers in the database, search with useful filters, …
No Trip Needed
</pre> New compound shows potential benefits of psychedelics, without the trip PsychLight, a new genetically-encoded sensor, can predict whether a molecule will activate serotonin receptors which cause hallucinations. With this tool, scientists have identified a …
ATAI Files S-1
ATAI continues public market push, mushroom drinks are here, the Aussies make another run at rescheduling, PhamaTher battles Parkinson’s and Beckley gets to training.
Hallucinogenic effects not necessary?
The Research Briefing is powered by Blossom, a psychedelic research database. Blossom helps you find scientific insights in this new blossoming era of psychedelic research. Find the latest papers in the database, search with useful filters, …
Same, Same?
</pre> An Unusual Candidate is Pitching for Magic Mushrooms Former Republican Governor of Texas, Rick “I really wanted to be your President” Perry, is throwing his political weight behind a bill presented by none other …
Psychedelic Creativity?
Fewer creative thoughts under the influence of psilocybin It’s been a story told many times over, the use of psychedelics that sparked a creative insight. Steve Jobs described taking LSD as one of his most …
Psychedelic Grad Students
UW-Madison starts psychedelic masters program, California decrim pushes ahead as another Mass city looks to do the same. MindMed releases latest study results.
The positives of ketamine and negatives of ayahuasca
The Research Briefing is powered by Blossom, a psychedelic research database. Blossom helps you find scientific insights in this new blossoming era of psychedelic research. Find the latest papers in the database, search with useful filters, and learn …
Another University Takes A Trip
</pre> UCSF Private Funding To Form Neuroscape Division The University of California, San Francisco (UCSF) is advancing psychedelic research and treatments with a $6.4 million in funding. The university’s new ‘Neuroscape Psychedelics Division’ will focus …
Get Report on Psychedelics Case Study: Mind Medicine Inc.
MindMed is a biopharmaceutical company focused on medicines to alleviate suffering and improve mental health and the first pure play psychedelics company to be publicly traded with their March 2020 listing on the NEO Exchange. This …